4//SEC Filing
Saad Mark E 4
Accession 0000950170-24-023374
CIK 0001579428other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 6:34 PM ET
Size
5.3 KB
Accession
0000950170-24-023374
Insider Transaction Report
Form 4
Saad Mark E
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-02-27+1,519→ 1,519 totalExercise: $84.00From: 2024-02-27Exp: 2034-02-26→ Common Stock (1,519 underlying)
Footnotes (1)
- [F1]Represents 1,519 options elected to be received in lieu of cash compensation earned in 2023. All of such options are immediately exercisable.
Documents
Issuer
Axsome Therapeutics, Inc.
CIK 0001579428
Entity typeother
Related Parties
1- filerCIK 0001295913
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 6:34 PM ET
- Size
- 5.3 KB